XML 46 R36.htm IDEA: XBRL DOCUMENT v3.22.2.2

Interest in joint venture (Tables)

9 Months Ended

Sep. 30, 2022

Interests In Other Entities [Abstract]

Schedule of movement in interest in joint venture

The table below provides a rollforward of the Company’s interest in Overland ADCT BioPharma as of September 30, 2022 and 2021, respectively.

(in KUSD)
Interest in joint venture
January 1, 2022						41,236
Share of results in joint venture						(6,549)
September 30, 2022						34,687
January 1, 2021						47,908
Share of results in joint venture						(3,906)
September 30, 2021						44,002

Summary of financial information in join venture

The tables below provide summarized financial information for Overland ADCT BioPharma that is material to the Company. The following information reflects the amounts presented in the financial statements of Overland ADCT BioPharma and not the Company’s share of those amounts.

(in KUSD)						As of
Summarized Balance Sheet						September 30, 2022						December 31, 2021
Cash and cash equivalents						24,445						39,318
Prepaid and other current assets						516						15
Intangible assets						48,040						48,040
Total liabilities						3,711						2,828
Net assets						69,290						84,545
Summarized Statement of Comprehensive Loss						Three months ended September 30,												Nine months ended September 30,
						2022						2021						2022						2021
Operating expenses						4,950						4,465						14,317						8,120
Net loss						4,346						4,511						13,009						7,972

X

- Definition

Interests In Other Entities [Abstract]

+ References

No definition available.

+ Details

Name:	adc_InterestsInOtherEntitiesAbstract
Namespace Prefix:	adc_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of interests in joint arrangements. A joint arrangement is an arrangement of which two or more parties have joint control.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2022-03-24
-Paragraph 2
-Subparagraph b
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_2_b_ii&doctype=Standard
-URIDate 2022-03-24

+ Details

Name:	ifrs-full_DisclosureOfInterestsInJointArrangementsExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of the reconciliation of the summarised financial information of a joint venture accounted for using the equity method to the carrying amount of the reporting entity's interest in the joint venture. [Refer: Carrying amount [member]; Joint ventures [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2022-03-24
-Paragraph B14
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B14_b&doctype=Appendix&subtype=B
-URIDate 2022-03-24

+ Details

Name:	ifrs-full_DisclosureOfReconciliationOfSummarisedFinancialInformationOfJointVentureAccountedForUsingEquityMethodToCarryingAmountOfInterestInJointVentureExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration